Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,517 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $549.17 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $320.38 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $177.14 | 5 | $0 (2024) |
| Amgen Inc. | $124.99 | 1 | $0 (2023) |
| Novo Nordisk Inc | $102.44 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $74.80 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.79 | 3 | $0 (2024) |
| Lilly USA, LLC | $30.23 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $30.08 | 2 | $0 (2017) |
| Phathom Pharmaceuticals, Inc. | $28.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $433.63 | 12 | AstraZeneca Pharmaceuticals LP ($294.49) |
| 2023 | $397.59 | 12 | GlaxoSmithKline, LLC. ($141.18) |
| 2022 | $263.32 | 4 | SANOFI-AVENTIS U.S. LLC ($231.88) |
| 2021 | $226.92 | 2 | SANOFI-AVENTIS U.S. LLC ($226.92) |
| 2019 | $90.37 | 1 | SANOFI-AVENTIS U.S. LLC ($90.37) |
| 2018 | $74.80 | 2 | Janssen Pharmaceuticals, Inc ($74.80) |
| 2017 | $30.08 | 2 | Sunovion Pharmaceuticals Inc. ($30.08) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 10/24/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Diabetes | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: DIABETES | ||||||
| 08/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $113.86 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 05/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Neuroscience | ||||||
| 05/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 05/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 76 | 94 | $15,850 | $7,237 |
| 2021 | 4 | 261 | 1,104 | $117,577 | $62,722 |
| 2020 | 4 | 264 | 1,153 | $121,495 | $66,030 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 45 | $5,850 | $2,741 | 46.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $5,950 | $2,102 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 17 | $2,550 | $1,365 | 53.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 14 | 15 | $1,500 | $1,029 | 68.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 121 | 857 | $82,272 | $44,703 | 54.3% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 71 | 92 | $17,020 | $9,137 | 53.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 36 | 120 | $15,240 | $6,893 | 45.2% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Office | 2021 | 33 | 35 | $3,045 | $1,989 | 65.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 123 | 922 | $88,420 | $47,870 | 54.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 50 | 126 | $16,002 | $8,535 | 53.3% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2020 | 67 | 81 | $14,985 | $8,238 | 55.0% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Office | 2020 | 24 | 24 | $2,088 | $1,387 | 66.4% |
About Dr. Frederick Beck, MD
Dr. Frederick Beck, MD is a Family Medicine healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235122326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederick Beck, MD has received a total of $1,517 in payments from pharmaceutical and medical device companies, with $433.63 received in 2024. These payments were reported across 35 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,517).
As a Medicare-enrolled provider, Beck has provided services to 601 Medicare beneficiaries, totaling 2,351 services with total Medicare billing of $135,989. Data is available for 3 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williamsville, NY
- Active Since 08/24/2005
- Last Updated 01/28/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235122326
Products in Payments
- SOLIQUA 100/33 (Biological) $352.26
- FARXIGA (Drug) $262.64
- Repatha (Biological) $124.99
- AREXVY (Drug) $113.86
- TOUJEO (Biological) $106.54
- SOLIQUA 100/33 (Drug) $90.37
- TRELEGY ELLIPTA (Drug) $63.28
- XARELTO (Drug) $62.50
- Rybelsus (Drug) $62.49
- AIRSUPRA (Drug) $44.78
- Ozempic (Drug) $39.95
- BROVANA (Drug) $30.08
- STIOLTO RESPIMAT (Drug) $29.39
- VOQUEZNA (Drug) $28.41
- JARDIANCE (Drug) $19.40
- REXULTI (Drug) $17.53
- TRULICITY (Drug) $17.27
- BREZTRI (Drug) $12.96
- EMGALITY (Drug) $12.96
- NEXLETOL (Drug) $12.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsville
Jean Cange, M.d, M.D
Family Medicine — Payments: $28,012
Dr. Daniel Trock, M.d, M.D
Family Medicine — Payments: $22,227
Suchitra Koneru, M.d, M.D
Family Medicine — Payments: $15,123
Dr. David Pawlowski, Md, MD
Family Medicine — Payments: $14,600
Dr. Stacey Gugino, Md, MD
Family Medicine — Payments: $13,585
Dr. Karol Pohlman Rejman, Phd, Fnp, PHD, FNP
Family Medicine — Payments: $12,074